Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - somatropin -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - riluzole -

New Zealand - English - Medsafe (Medicines Safety Authority)

obex medical ltd - iodised oil 38%{relative} (eqv to 48% w/v iodine);   - solution for injection - 38% w/w - active: iodised oil 38%{relative} (eqv to 48% w/v iodine)   - in diagnostic radiology lipiodol ultra fluid is used in lymphography, hysterosalpingography in women undergoing infertility workup and sialography.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - riluzole 50mg - film coated tablet - 50 mg - active: riluzole 50mg excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium hypromellose macrogol 6000 magnesium stearate microcrystalline cellulose titanium dioxide - riluzole is indicated for the treatment of patients with amyotrophic lateral sclerosis (als).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - betahistine dihydrochloride 16mg;   - tablet - 16 mg - active: betahistine dihydrochloride 16mg   excipient: citric acid monohydrate colloidal silicon dioxide mannitol microcrystalline cellulose purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

russells pharmaceuticals ltd - betahistine dihydrochloride 4mg - tablet - 4 mg - active: betahistine dihydrochloride 4mg excipient: colloidal silicon dioxide erythrosine lactose monohydrate magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - betahistine dihydrochloride 8mg;   - tablet - 8 mg - active: betahistine dihydrochloride 8mg   excipient: citric acid monohydrate colloidal silicon dioxide mannitol microcrystalline cellulose purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - betahistine dihydrochloride 16mg;   - tablet - 16 mg - active: betahistine dihydrochloride 16mg   excipient: citric acid monohydrate colloidal silicon dioxide mannitol microcrystalline cellulose purified talc purified water - m?ni?re's syndrome as defined by the following core symptoms: · vertigo (with nausea/vomiting) · hearing loss (hardness of hearing) · tinnitus

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - betahistine dihydrochloride - tablets - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - alprazolam - tablet - 0.50 milligram(s) - benzodiazepine derivatives; alprazolam